RxDoctor Payments Data

Jeffrey Rapaport, MD

Procedural Dermatology · Englewood Cliffs, NJNPI 1629161989

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Merz North America, Inc. at 38.2% of the total.

$2,598in general payments, 2019–2025

Across 71 payments — averaging $36.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merz North America, Inc.$993
  • Revance Therapeutics, Inc.$648
  • Arcutis Biotherapeutics, Inc.$125
  • Pfizer$114
  • Dermavant Sciences, Inc.$103
  • Amgen$100
  • plus $516 from 14 others

What the payments were for

  • Food & beverage$2,598100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,598 in reported general payments places this provider in the 65th percentile of 22 procedural dermatology providers in New Jersey.

See all procedural dermatology providers in New Jersey

Medicare billing

Part B allowed, 2024
$29,157
Medicare patients
240
Services billed
285

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dapsone11$4,382
Tazarotene16$2,501
Clobetasol Propionate54$1,642
Minoxidil183$1,219
Dutasteride67$1,178
Doxycycline Hyclate40$895
ValacyclovirValacyclovir Hcl12$743
Spironolactone71$590
Mometasone Furoate37$547
Ketoconazole42$535
Clindamycin-Benzoyl PeroxideClindamycin Phos/Benzoyl Perox11$304
Finasteride21$296
Cephalexin27$197
Triamcinolone Acetonide13$98

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Englewood Cliffs

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →